Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction]
Dong Y, Chang C, Liu J, Qiang J. Onco Targets Ther. 2017;10:5873-5882.
The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of tumor images in Figure 4A. Specifically,
- Images in Figure 4A, panel NC appear to have been duplicated with the same images from Figure 4A, panel miR-149*.
- Images in Figure 4A, panel miR-149* inhibitor appear to have been duplicated with the same images from Figure 4A, panel GIT1 overexpression.
The authors did not respond to our queries and the Editor requested to retract the article. The authors were notified of this.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This retraction relates to this paper
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.